Technical Analysis for NTEC - Intec Pharma Ltd.

Grade Last Price % Change Price Change
grade F 5.15 -3.01% -0.16
NTEC closed down 3.01 percent on Monday, May 20, 2019, on 52 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Earnings due: May 21

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical NTEC trend table...

Date Alert Name Type % Chg
Stochastic Buy Signal Bullish 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Below Lower BB Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
Slingshot Bearish Bearish Swing Setup -3.01%
Doji - Bullish? Reversal -3.01%
Lower Bollinger Band Walk Weakness -3.01%
Outside Day Range Expansion -3.01%

Older signals for NTEC ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Intec Pharma Ltd., a drug development company, develops formulations of drugs using its proprietary gastric retention technology, the Accordion Pill, in Israel. The Accordion Pill, a novel gastro-retentive delivery system improves the pharmacokinetics and pharmacodynamics of various drugs. The company is focusing on the clinical development program for the Phase III clinical study of the Accordion Pill Carbidopa Levodopa (AP-CDLD), for the treatment of advanced stages Parkinson's disease patients. Its pipeline also comprises The Accordion Pill – Zaleplon, a drug for sleep onset, which is in Phase II clinical program. Intec Pharma Ltd. is based in Jerusalem, Israel.
Chemistry Physical Sciences Drugs Parkinson's Disease Drug Development Pharmacokinetics Pharmacodynamics L Dopa
Is NTEC a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 9.25
52 Week Low 3.55
Average Volume 250,175
200-Day Moving Average 6.2452
50-Day Moving Average 6.4766
20-Day Moving Average 5.897
10-Day Moving Average 5.616
Average True Range 0.3788
ADX 23.25
+DI 13.9405
-DI 19.1652
Chandelier Exit (Long, 3 ATRs ) 5.3836
Chandelier Exit (Short, 3 ATRs ) 6.2364
Upper Bollinger Band 6.6226
Lower Bollinger Band 5.1714
Percent B (%b) -0.01
BandWidth 24.609123
MACD Line -0.3684
MACD Signal Line -0.3137
MACD Histogram -0.0547
Fundamentals Value
Market Cap 70.75 Million
Num Shares 13.7 Million
EPS -1.50
Price-to-Earnings (P/E) Ratio -3.43
Price-to-Sales 0.00
Price-to-Book 5.22
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 5.45
Resistance 3 (R3) 5.47 5.38 5.40
Resistance 2 (R2) 5.38 5.31 5.38 5.38
Resistance 1 (R1) 5.27 5.26 5.23 5.25 5.37
Pivot Point 5.18 5.18 5.16 5.18 5.18
Support 1 (S1) 5.07 5.11 5.03 5.05 4.93
Support 2 (S2) 4.98 5.06 4.98 4.92
Support 3 (S3) 4.87 4.98 4.90
Support 4 (S4) 4.85